Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's

Authors not listed

University of Wisconsin, Madison · 2009

Abstract

Angiotensin converting enzyme inhibitors (ACE-I) are a group of blood pressure-lowering medicines. Some studies suggest that ACE-I, such as ramipril, may help prevent Alzheimer's disease (AD). The purpose of the research is to see how ramipril affects a substance in the body called beta-amyloid. Beta-amyloid is found in the brain and in the liquid around the brain and spinal cord. High amounts of beta-amyloid may be associated with a greater risk of getting Alzheimer's disease. This study will see if ramipril can lower the amount of beta-amyloid in the spinal fluid. This study will also see if ramipril affects blood vessel function and memory and thinking. The investigators hope that future studies will show whether ramipril might prevent memory loss and decrease the chance of developing Alzheimer's disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-11 MST

Cite this

APA
Anonymous. (2009). Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's. <em>University of Wisconsin, Madison</em>. https://clinicaltrials.gov/study/NCT00980785
Vancouver
Anonymous. Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's. University of Wisconsin, Madison. 2009.
BibTeX
@misc{anon2009Studyi, title = {Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's}, author = {Anonymous}, journal = {University of Wisconsin, Madison}, year = {2009}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings